Paper Details

  1. Home
  2. Paper Details

Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis.

Author: GraceAngeline G, JainSiddharth, KirubakaranRichard, MittalAbhenil, SatyanarayanaSrinath, TharyanPrathap, TripathyJaya P

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Tuberculosis (TB) is the leading cause of death from infectious disease worldwide. The standard treatment for drug-sensitive TB in the lungs is a six-month course of medications. Many people don't complete the full course of treatment. Research is looking for shorter and equally effective treatments for TB.
Paper Details　
Original Abstract of the Article :
Tuberculosis causes more deaths than any other infectious disease worldwide, with pulmonary tuberculosis being the most common form. Standard first-line treatment for drug-sensitive pulmonary tuberculosis for six months comprises isoniazid, rifampicin, pyrazinamide, and ethambutol (HRZE) for two mon...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953336/

データ提供：米国国立医学図書館（NLM）

Shortened Regimens for Drug-Sensitive Pulmonary Tuberculosis

This research explores the world of infectious disease treatment, specifically focusing on drug-sensitive pulmonary tuberculosis. Imagine a patient, battling this chronic infection, seeking an effective and tolerable treatment regimen. This research aims to investigate the feasibility of shortened treatment regimens.

The study reviews the current standard regimen for drug-sensitive pulmonary tuberculosis, which involves a six-month course of medication. The researchers highlight the challenges of patient adherence to this lengthy regimen and explore the potential benefits of shortened regimens that maintain efficacy and safety.

The study emphasizes the importance of finding shorter and more effective treatment regimens for drug-sensitive pulmonary tuberculosis to improve treatment success and reduce the burden of this disease.

Improving Treatment Adherence: A Key to Success

This research highlights the critical role of treatment adherence in achieving successful outcomes for patients with tuberculosis. It underscores the need for shorter, more manageable regimens that can enhance patient compliance and ultimately lead to better treatment outcomes.

Dr. Camel's Conclusion

This research is a beacon of hope in the fight against tuberculosis, reminding us that innovation and a focus on patient needs can pave the way for more effective treatment strategies. It's a reminder that the quest for better treatments is an ongoing journey, fueled by a commitment to improving the health and well-being of those affected by this devastating disease.

Date :
  1. Date Completed 2020-04-30
  2. Date Revised 2022-09-07
Further Info :

Pubmed ID

31828771

DOI: Digital Object Identifier

PMC6953336

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.